MBX Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $385.1M
Liabilities Breakdown FY2025
Total Liabilities: $15.9M
Asset Breakdown
Total Assets: $385.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $75.3M | 19.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.7M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $307.1M | 79.7% |
Liabilities Breakdown
Total Liabilities: $15.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 18.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $12.9M | 81.3% |